1. Home
  2. WSBK vs ASMB Comparison

WSBK vs ASMB Comparison

Compare WSBK & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WSBK
  • ASMB
  • Stock Information
  • Founded
  • WSBK 2024
  • ASMB 2005
  • Country
  • WSBK United States
  • ASMB United States
  • Employees
  • WSBK N/A
  • ASMB N/A
  • Industry
  • WSBK
  • ASMB Biotechnology: Pharmaceutical Preparations
  • Sector
  • WSBK
  • ASMB Health Care
  • Exchange
  • WSBK NYSE
  • ASMB Nasdaq
  • Market Cap
  • WSBK 86.4M
  • ASMB 76.9M
  • IPO Year
  • WSBK N/A
  • ASMB 2010
  • Fundamental
  • Price
  • WSBK $9.35
  • ASMB $14.78
  • Analyst Decision
  • WSBK
  • ASMB Strong Buy
  • Analyst Count
  • WSBK 0
  • ASMB 3
  • Target Price
  • WSBK N/A
  • ASMB $33.00
  • AVG Volume (30 Days)
  • WSBK 76.7K
  • ASMB 18.2K
  • Earning Date
  • WSBK 01-01-0001
  • ASMB 05-08-2025
  • Dividend Yield
  • WSBK N/A
  • ASMB N/A
  • EPS Growth
  • WSBK N/A
  • ASMB N/A
  • EPS
  • WSBK 0.02
  • ASMB N/A
  • Revenue
  • WSBK $15,687,000.00
  • ASMB $32,154,000.00
  • Revenue This Year
  • WSBK N/A
  • ASMB $33.96
  • Revenue Next Year
  • WSBK N/A
  • ASMB N/A
  • P/E Ratio
  • WSBK $568.59
  • ASMB N/A
  • Revenue Growth
  • WSBK N/A
  • ASMB 148.33
  • 52 Week Low
  • WSBK $8.91
  • ASMB $7.75
  • 52 Week High
  • WSBK $10.10
  • ASMB $19.93
  • Technical
  • Relative Strength Index (RSI)
  • WSBK N/A
  • ASMB 67.63
  • Support Level
  • WSBK N/A
  • ASMB $13.13
  • Resistance Level
  • WSBK N/A
  • ASMB $14.35
  • Average True Range (ATR)
  • WSBK 0.00
  • ASMB 0.66
  • MACD
  • WSBK 0.00
  • ASMB 0.07
  • Stochastic Oscillator
  • WSBK 0.00
  • ASMB 99.20

About WSBK WINCHESTER BANCORP INC

Winchester Bancorp Inc provides a variety of financial services to individuals and small businesses through its offices in Winchester, Woburn, Danvers and Arlington, Massachusetts. Its primary deposit products are checking, savings and term certificate accounts and its primary lending products are residential and commercial real estate loans.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: